Cargando…
Structure-Based Evolution of Subtype-Selective Neurotensin Receptor Ligands
Subtype-selective agonists of the neurotensin receptor NTS2 represent a promising option for the treatment of neuropathic pain, as NTS2 is involved in the mediation of μ-opioid-independent anti-nociceptive effects. Based on the crystal structure of the subtype NTS1 and previous structure–activity re...
Autores principales: | Schaab, Carolin, Kling, Ralf Christian, Einsiedel, Jürgen, Hübner, Harald, Clark, Tim, Seebach, Dieter, Gmeiner, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4234217/ https://www.ncbi.nlm.nih.gov/pubmed/25478316 http://dx.doi.org/10.1002/open.201402031 |
Ejemplares similares
-
Theranostic Value of Multimers: Lessons Learned from Trimerization of Neurotensin Receptor Ligands and Other Targeting Vectors
por: Maschauer, Simone, et al.
Publicado: (2017) -
Structure-guided development of heterodimer-selective GPCR ligands
por: Hübner, Harald, et al.
Publicado: (2016) -
In Vivo Monitoring of the Antiangiogenic Effect of Neurotensin Receptor-Mediated Radiotherapy by Small-Animal Positron Emission Tomography: A Pilot Study
por: Maschauer, Simone, et al.
Publicado: (2014) -
Active-State Models of Ternary GPCR Complexes: Determinants of Selective Receptor-G-Protein Coupling
por: Kling, Ralf C., et al.
Publicado: (2013) -
Synthesis, Radiosynthesis and Biological Evaluation of Buprenorphine‐Derived Phenylazocarboxamides as Novel μ‐Opioid Receptor Ligands
por: Krüll, Jasmin, et al.
Publicado: (2020)